These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3960042)

  • 1. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 3. The concept of negativity in experimental carcinogenesis.
    Clayson DB; Krewski D
    Mutat Res; 1986 May; 167(3):233-40. PubMed ID: 3960042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 13. The need for biological risk assessment in reaching decisions about carcinogens.
    Clayson DB
    Mutat Res; 1987 May; 185(3):243-69. PubMed ID: 3574332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: carcinogens and carcinogenesis enhancers.
    Clayson DB
    Mutat Res; 1981 Mar; 86(2):217-29. PubMed ID: 7266570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/4: Critical assessment of the value of in vitro cell transformation for predicting in vivo carcinogenicity of chemicals.
    Brookes P
    Mutat Res; 1981 Mar; 86(2):233-42. PubMed ID: 7266571
    [No Abstract]   [Full Text] [Related]  

  • 5. International Commission for Protection against Environmental Mutagens and Carcinogens ICPEMC working paper 2/8: An evaluation of assay procedures for detection of tumor promotors.
    Sivak A
    Mutat Res; 1982 May; 98(3):377-87. PubMed ID: 7050698
    [No Abstract]   [Full Text] [Related]  

  • 6. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 12. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC Expert Group on Antimutagens and Desmutagens.
    Ramel C; Alekperov UK; Ames BN; Kada T; Wattenberg LW
    Mutat Res; 1986 Jul; 168(1):47-65. PubMed ID: 3520303
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive and false-negative rates for carcinogenicity screens.
    Fears TR; Tarone RE; Chu KC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1941-5. PubMed ID: 861930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 17. Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays?
    Clayson DB
    Mutat Res; 1989 Jul; 221(1):53-67. PubMed ID: 2664495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response problems in carcinogenesis.
    Crump KS
    Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-mediated in vivo-in vitro assay for chemical carcinogenesis.
    DiPaolo JA; Nelson RL; Donovan PJ; Evans CH
    Arch Pathol; 1973 Jun; 95(6):380-5. PubMed ID: 4701393
    [No Abstract]   [Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 2. Diet, mutation and cancer.
    Clayson DB
    Mutat Res; 1985 Nov; 154(3):205-17. PubMed ID: 3900715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Topic No. 1. Are somatic mutations involved in atherosclerosis?
    Bridges BA
    Mutat Res; 1987 Dec; 182(6):301-2. PubMed ID: 3683430
    [No Abstract]   [Full Text] [Related]  

  • 17. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Commission for Protection against Environmental Mutagens and Carcinogens: ICPEMC news no. 2.
    Sobels FH
    Mutat Res; 1979 Oct; 64(5):357-61. PubMed ID: 514300
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.